Overview

Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
PAES, double blind, double dummy, multicenter, randomized, controlled clinical study to demonstrate superiority of Tricortin 1000 over placebo in improvement in pain relief as change from baseline to 15 days in patients with chronic low back pain (LBP).
Phase:
Phase 4
Details
Lead Sponsor:
Fidia Farmaceutici s.p.a.
Treatments:
Diclofenac